INFANTILE MYOFIBROMATOSIS

Clinical trials for INFANTILE MYOFIBROMATOSIS explained in plain language.

Never miss a new study

Get alerted when new INFANTILE MYOFIBROMATOSIS trials appear

Sign up with your email to follow new studies for INFANTILE MYOFIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill tested in kids with Hard-to-Treat cancers

Disease control Ongoing

This study is testing a pill called LOXO-292 in children and teenagers with advanced solid or brain tumors that have a specific genetic change called a RET alteration. The goal is to find a safe and effective dose and to see if the medicine can shrink these difficult-to-treat tum…

Matched conditions: INFANTILE MYOFIBROMATOSIS

Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

INFANTILE MYOFIBROMATOSIS

Get alerted when new INFANTILE MYOFIBROMATOSIS trials appear

New pill tested in kids with Hard-to-Treat cancers